rank	phenotype	cui	assoc in neigh	assoc in intom	probability	Benjamini-Hochberg	genes	
7	Amaurosis fugax	C0149793	4	40	0.0	8.130081300813009e-06	MLH1,PMS2,MSH2,MSH6
13	Cafe-au-lait spot	C0221263	4	81	1.23926424678e-11	1.5098722415795587e-05	MLH1,PMS2,MSH2,MSH6
14	Mucinous Adenocarcinoma	C0007130	4	86	1.97688532211e-11	1.6260162601626018e-05	MLH1,PMS2,MSH2,MSH6
17	Colorectal polyposis	C0949059	4	66	2.71174194211e-11	1.9744483159117308e-05	MLH1,PMS2,MSH2,MSH6
18	Freckling	C0016689	4	52	2.98936431165e-11	2.0905923344947736e-05	MLH1,PMS2,MSH2,MSH6
19	Neoplasm of the skeletal system	C2732838	4	52	2.98936431165e-11	2.2067363530778164e-05	MLH1,PMS2,MSH2,MSH6
20	Nervous tissue neoplasm	C0027665	4	52	2.98936431165e-11	2.3228803716608595e-05	MLH1,PMS2,MSH2,MSH6
21	Microsatellite Instability	C0796369	4	63	3.46860318245e-11	2.4390243902439026e-05	MLH1,MSH3,MSH2,MSH6
22	Genital neoplasm	C0679347	5	85	3.64130947617e-11	2.5551684088269457e-05	MLH1,MSH3,PMS2,MSH2,MSH6
23	Pituitary adenoma	C0032000	5	286	3.66877639379e-11	2.6713124274099885e-05	MLH1,PCNA,PMS2,MSH2,MSH6
24	Hereditary cancer-predisposing syndrome	C0027672	4	58	3.97991639645e-11	2.7874564459930316e-05	MLH1,PMS2,MSH2,MSH6
25	Familial colorectal cancer	C1333600	4	71	4.13147294154e-11	2.9036004645760743e-05	MLH1,PMS2,MSH2,MSH6
26	keratoacanthoma	C0022572	4	34	4.33677538325e-11	3.0197444831591174e-05	MLH1,PCNA,MSH2,MSH6
27	Peripheral neuroepithelioma	C0684337	4	34	4.33677538325e-11	3.1358885017421605e-05	MLH1,PMS2,MSH2,MSH6
29	Dysgraphia	C0234144	4	31	4.93294294301e-11	3.368176538908246e-05	MLH1,PMS2,MSH2,MSH6
30	Neoplasm of the larynx	C0023055	4	106	5.08696418322e-11	3.484320557491289e-05	MLH1,PCNA,MSH2,MSH6
31	Thyroid Neoplasms	C0040136	6	486	5.18202147859e-11	3.600464576074332e-05	MLH1,PCNA,MSH3,PMS2,MSH2,MSH6
32	Intestinal polyposis	C1257915	4	53	5.26584331695e-11	3.7166085946573754e-05	MLH1,PMS2,MSH2,MSH6
33	Genitourinary neoplasm	C0042065	5	141	5.3002935374e-11	3.832752613240418e-05	MLH1,MSH3,PMS2,MSH2,MSH6
34	FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder)	C3469521	5	223	5.31933386227e-11	3.9488966318234616e-05	MLH1,PCNA,MSH3,MSH2,MSH6
36	Neoplasm of the rectum	C0034885	5	105	5.43388667396e-11	4.181184668989547e-05	MLH1,PCNA,PMS2,MSH2,MSH6
37	Endometrial Neoplasms	C0014170	5	268	5.51881873534e-11	4.29732868757259e-05	MLH1,PCNA,PMS2,MSH2,MSH6
41	Abnormality of intracranial pressure	C4022809	4	56	5.64595037389e-11	4.761904761904762e-05	MLH1,PMS2,MSH2,MSH6
42	Neoplasm of the endocrine system	C0014132	4	111	5.71012126471e-11	4.878048780487805e-05	MLH1,PMS2,MSH2,MSH6
45	Hereditary nonpolyposis colorectal cancer type 8	C1333990	5	119	5.87231374638e-11	5.226480836236934e-05	MLH1,MSH3,PMS2,MSH2,MSH6
47	Benign neoplasm of the central nervous system	C0347509	4	45	5.99590377348e-11	5.45876887340302e-05	MLH1,PMS2,MSH2,MSH6
48	Gastrointestinal hemorrhage	C0017181	4	133	6.00294258746e-11	5.574912891986063e-05	MLH1,PMS2,MSH2,MSH6
50	Death in early adulthood	C4022012	4	44	6.13593620358e-11	5.8072009291521487e-05	MLH1,PMS2,MSH2,MSH6
51	Astrocytoma	C0004114	6	674	6.20562490283e-11	5.923344947735192e-05	MLH1,PCNA,MSH3,PMS2,MSH2,MSH6
52	Basal cell carcinoma	C0007117	5	136	6.32284224977e-11	6.039488966318235e-05	MLH1,MSH3,PMS2,MSH2,MSH6
53	Neuroepithelial neoplasm	C0206715	4	65	6.4246385989e-11	6.155632984901277e-05	MLH1,PMS2,MSH2,MSH6
54	Gonadal neoplasm	C0239763	4	65	6.4246385989e-11	6.271777003484321e-05	MLH1,PMS2,MSH2,MSH6
55	Rash and Dermatitis Adverse Event Associated with Chemoradiation	C1559154	4	80	6.53654907978e-11	6.387921022067364e-05	MLH1,PMS2,MSH2,MSH6
57	Endometrial carcinoma	C0476089	6	726	6.91100510153e-11	6.62020905923345e-05	MLH1,PCNA,MSH3,PMS2,MSH2,MSH6
58	Neuroblastic tumors	C1334953	4	42	6.93891610837e-11	6.736353077816492e-05	MLH1,PMS2,MSH2,MSH6
59	Memory impairment	C0233794	5	255	7.16394721323e-11	6.852497096399536e-05	MLH1,PCNA,PMS2,MSH2,MSH6
60	Neuroectodermal neoplasm	C0206093	4	104	7.16535719647e-11	6.968641114982578e-05	MLH1,PMS2,MSH2,MSH6
61	Adenocarcinoma of colon	C0338106	5	240	7.24633686389e-11	7.084785133565622e-05	MLH1,PCNA,MSH3,MSH2,MSH6
62	Sarcoma, Ewing	C1261473	6	829	7.3286376967e-11	7.200929152148665e-05	MLH1,PCNA,MSH3,PMS2,MSH2,MSH6
63	Laryngeal carcinoma	C0595989	5	184	7.38852312665e-11	7.317073170731707e-05	MLH1,PCNA,MSH3,MSH2,MSH6
64	Macule	C0332573	4	98	7.40250083453e-11	7.433217189314751e-05	MLH1,PMS2,MSH2,MSH6
65	Abnormality of the rectum	C0266210	4	64	7.53601625547e-11	7.549361207897793e-05	MLH1,PMS2,MSH2,MSH6
66	Pituitary Neoplasms	C0032019	5	321	7.5645822939e-11	7.665505226480836e-05	MLH1,PCNA,PMS2,MSH2,MSH6
67	Gastrointestinal carcinoma	C0151544	4	41	7.80880915485e-11	7.78164924506388e-05	MLH1,PMS2,MSH2,MSH6
71	Urinary tract neoplasm	C0042076	4	115	8.09102784771e-11	8.246225319396052e-05	MLH1,PMS2,MSH2,MSH6
72	Uterine neoplasm	C0042138	5	77	8.22865109384e-11	8.362369337979094e-05	MLH1,MSH3,PMS2,MSH2,MSH6
73	Neoplasm of the anterior pituitary	C4023205	4	25	8.29473156827e-11	8.478513356562137e-05	MLH1,PMS2,MSH2,MSH6
74	Irregular hyperpigmentation	C1860236	4	117	8.35878033456e-11	8.59465737514518e-05	MLH1,PMS2,MSH2,MSH6
75	Turcot syndrome	C0265325	5	62	8.36036795349e-11	8.710801393728224e-05	MLH1,MSH3,PMS2,MSH2,MSH6
76	Malignant neoplasm of the central nervous system	C0348374	4	61	8.38725755514e-11	8.826945412311265e-05	MLH1,PMS2,MSH2,MSH6
77	Malignant neoplasm of endometrium	C0007103	6	506	8.42386160826e-11	8.943089430894309e-05	MLH1,PCNA,MSH3,PMS2,MSH2,MSH6
78	Uterine Corpus Cancer	C0153574	6	506	8.42386160826e-11	9.059233449477353e-05	MLH1,PCNA,MSH3,PMS2,MSH2,MSH6
79	Fanconi anemia	C0015625	5	249	8.46074321714e-11	9.175377468060394e-05	MLH1,PCNA,MSH3,MSH2,MSH6
80	Abnormal uterus morphology	C0266383	5	158	8.68553007294e-11	9.291521486643438e-05	MLH1,MSH3,PMS2,MSH2,MSH6
83	Brain neoplasm	C0006118	6	667	9.40599820254e-11	9.639953542392567e-05	MLH1,PCNA,MSH3,PMS2,MSH2,MSH6
84	Leukemia, T-cell acute lymphoblastoid (2)	C0023492	5	348	9.45536982044e-11	9.75609756097561e-05	MLH1,PCNA,MSH3,MSH2,MSH6
85	Abnormality of the large intestine	C4025715	4	123	9.59228252384e-11	9.872241579558653e-05	MLH1,PMS2,MSH2,MSH6
86	Pancreatic Neoplasms	C0030297	6	750	9.60509449754e-11	9.988385598141695e-05	MLH1,PCNA,MSH3,PMS2,MSH2,MSH6
87	Malignant gastrointestinal tract tumors	C0685938	5	251	9.76102532135e-11	0.00010104529616724739	MLH1,MSH3,PMS2,MSH2,MSH6
88	Ependymoma	C0014474	4	121	9.78140901609e-11	0.00010220673635307783	MLH1,PMS2,MSH2,MSH6
89	Increased intracranial pressure	C0151740	4	59	1.04051434135e-10	0.00010336817653890825	MLH1,PMS2,MSH2,MSH6
90	Hypermelanotic macule	C1842774	4	59	1.04051434135e-10	0.00010452961672473868	MLH1,PMS2,MSH2,MSH6
91	Abnormality of the glial cells	C4021993	4	88	1.04996566996e-10	0.00010569105691056911	MLH1,PMS2,MSH2,MSH6
92	Rhabdomyosarcoma alveolar	C0035412	5	381	1.06772479747e-10	0.00010685249709639954	MLH1,PCNA,PMS2,MSH2,MSH6
93	Undifferentiated carcinoma	C0205698	4	83	1.08142717004e-10	0.00010801393728222996	MLH1,PCNA,PMS2,MSH2
94	Abnormality of thyroid morphology	C4023195	4	107	1.09273701199e-10	0.0001091753774680604	MLH1,PMS2,MSH2,MSH6
95	Intestinal polyp	C0021846	4	84	1.09660391878e-10	0.00011033681765389082	MLH1,PMS2,MSH2,MSH6
96	Adenocarcinoma of the large intestine	C1319315	5	189	1.09882103416e-10	0.00011149825783972126	MLH1,PCNA,MSH3,PMS2,MSH6
97	Polyposis syndrome, mixed hereditary 1 (4)	C0334108	4	74	1.10257691865e-10	0.00011265969802555169	MLH1,PMS2,MSH2,MSH6
98	Dysarthria	C0013362	5	335	1.15139564549e-10	0.00011382113821138211	MLH1,PCNA,PMS2,MSH2,MSH6
99	Dyskinesia, seizures, and intellectual developmental disorder	C0013384	4	97	1.15361609154e-10	0.00011498257839721255	MLH1,PMS2,MSH2,MSH6
100	Irritability	C0022107	4	97	1.15361609154e-10	0.00011614401858304297	MLH1,PMS2,MSH2,MSH6
101	Paresthesia	C0030554	4	97	1.15361609154e-10	0.0001173054587688734	MLH1,PMS2,MSH2,MSH6
103	Hallucinations	C0018524	4	126	1.27458821275e-10	0.00011962833914053427	MLH1,PMS2,MSH2,MSH6
104	Short attention span	C0262630	4	128	1.27625243707e-10	0.0001207897793263647	MLH1,PMS2,MSH2,MSH6
105	Chronic obstructive pulmonary disease	C0024117	6	865	1.28405841515e-10	0.00012195121951219512	MLH1,PCNA,MSH3,PMS2,MSH2,MSH6
106	Intestinal Neoplasms	C0021841	4	145	1.31080590826e-10	0.00012311265969802555	MLH1,MSH3,MSH2,MSH6
107	Neoplasm of the central nervous system	C0085136	4	145	1.31080590826e-10	0.000124274099883856	MLH1,PMS2,MSH2,MSH6
108	Death in infancy	C1858430	4	125	1.45114031902e-10	0.00012543554006968642	MLH1,PMS2,MSH2,MSH6
109	Ovarian Neoplasms	C0919267	6	942	1.46808898371e-10	0.00012659698025551682	MLH1,PCNA,MSH3,PMS2,MSH2,MSH6
110	Familial adenomatous polyposis 1	C0032580	5	395	1.4846512908e-10	0.00012775842044134727	MLH1,PCNA,PMS2,MSH2,MSH6
111	Visual field defect	C3887875	4	151	1.61505586682e-10	0.0001289198606271777	MLH1,PMS2,MSH2,MSH6
112	Neoplasm of the nervous system	C0027766	4	139	1.63101643302e-10	0.00013008130081300815	MLH1,PMS2,MSH2,MSH6
113	Abnormality of female internal genitalia	C4025900	5	398	1.68369318487e-10	0.00013124274099883857	MLH1,MSH3,PMS2,MSH2,MSH6
114	Adenomas, multiple colorectal, 608456 (3)	C0001430	6	975	1.73068337439e-10	0.000132404181184669	MLH1,PCNA,MSH3,PMS2,MSH2,MSH6
115	Clear cell sarcoma, of tendons and aponeuroses	C0206651	3	40	1.73346892396e-10	0.00013356562137049945	MLH1,MSH2,MSH6
116	Abnormal internal genitalia	C4025824	5	426	1.74200986969e-10	0.00013472706155632984	MLH1,MSH3,PMS2,MSH2,MSH6
117	Primitive neuroectodermal tumor	C0206663	4	157	2.13327577825e-10	0.00013588850174216027	MLH1,PMS2,MSH2,MSH6
118	Flexion contracture	C0333068	5	436	2.16073936521e-10	0.00013704994192799072	MLH1,PCNA,PMS2,MSH2,MSH6
119	Sporadic Breast Carcinoma	C1336076	4	147	2.1960688823e-10	0.00013821138211382114	MLH1,PCNA,MSH3,MSH2
120	Familial cancer of breast	C0346153	4	155	2.22032836561e-10	0.00013937282229965157	MLH1,MSH3,MSH2,MSH6
121	Neoplasm of the skin	C0037286	5	438	2.22775797809e-10	0.00014053426248548202	MLH1,PCNA,PMS2,MSH2,MSH6
122	invasive cancer	C0677898	4	150	2.23520757459e-10	0.00014169570267131244	PCNA,PMS2,MSH2,MSH6
123	Abnormal tendon morphology	C4021026	5	449	2.35898522938e-10	0.00014285714285714284	MLH1,PCNA,PMS2,MSH2,MSH6
124	Abnormality of the female genitalia	C4023820	5	449	2.35898522938e-10	0.0001440185830429733	MLH1,MSH3,PMS2,MSH2,MSH6
125	Hemiplegia/hemiparesis	C0375206	4	166	2.86605517097e-10	0.00014518002322880372	MLH1,PMS2,MSH2,MSH6
126	Angiofibromas	C0206731	3	42	2.87274759536e-10	0.00014634146341463414	MLH1,MSH2,MSH6
127	Abnormality of amino acid metabolism	C1328440	4	172	3.02405656072e-10	0.0001475029036004646	MLH1,PMS2,MSH2,MSH6
129	Developmental regression	C1836830	4	170	3.04516190042e-10	0.00014982578397212544	MLH1,PMS2,MSH2,MSH6
130	Gait disturbance	C0575081	5	481	3.22374349437e-10	0.00015098722415795587	MLH1,PCNA,PMS2,MSH2,MSH6
131	Functional abnormality of the gastrointestinal tract	C4022755	5	470	3.27314397808e-10	0.0001521486643437863	MLH1,PCNA,PMS2,MSH2,MSH6
132	Adult T-Cell Lymphoma/Leukemia	C0023493	5	469	3.33310712364e-10	0.00015331010452961671	MLH1,PCNA,MSH3,MSH2,MSH6
133	Fibrous tissue neoplasm	C0206643	3	45	3.49894224705e-10	0.00015447154471544717	MLH1,MSH2,MSH6
134	Abnormality of the ovary	C4021818	4	171	3.5490632655e-10	0.0001556329849012776	MLH1,PMS2,MSH2,MSH6
135	Internal hemorrhage	C0333285	4	174	3.56708107496e-10	0.00015679442508710801	MLH1,PMS2,MSH2,MSH6
136	Abnormal fear/anxiety-related behavior	C4018849	4	177	3.77747499947e-10	0.00015795586527293847	MLH1,PMS2,MSH2,MSH6
137	Hyperpigmentation of the skin	C0162834	4	177	3.77747499947e-10	0.00015911730545876886	MLH1,PMS2,MSH2,MSH6
138	Neoplasm of the respiratory system	C0035244	3	46	3.97872623736e-10	0.0001602787456445993	MLH1,MSH2,MSH6
139	Sensory neuropathy	C0151313	4	185	4.19617895986e-10	0.00016144018583042974	MLH1,PMS2,MSH2,MSH6
140	Abnormality of the anterior pituitary	C4023206	4	181	4.23209134404e-10	0.00016260162601626016	MLH1,PMS2,MSH2,MSH6
141	Abdominal pain	C0000737	4	187	4.47453074592e-10	0.0001637630662020906	MLH1,PMS2,MSH2,MSH6
142	Colorectal Neoplasms	C0009404	6	1164	4.51306658711e-10	0.00016492450638792104	MLH1,PCNA,MSH3,PMS2,MSH2,MSH6
143	Friedreich's ataxia	C0016719	3	49	4.90759877181e-10	0.00016608594657375146	MLH1,PMS2,MSH2
146	Abnormality of blood circulation	C4023585	4	189	5.4022475382e-10	0.00016957026713124274	MLH1,PMS2,MSH2,MSH6
147	Tuberous sclerosis syndrome	C0041341	4	192	5.46866996132e-10	0.0001707317073170732	MLH1,PCNA,MSH2,MSH6
148	Neoplasm by histology	C4023186	4	193	5.59529089728e-10	0.0001718931475029036	MLH1,PMS2,MSH2,MSH6
149	Abnormality of carboxylic acid metabolism	C4025344	4	197	6.1827143405e-10	0.00017305458768873404	MLH1,PMS2,MSH2,MSH6
150	Endometrial Hyperplasia	C0014173	3	54	6.46442011032e-10	0.0001742160278745645	MLH1,PCNA,MSH2
151	Fibroma	C0016045	3	54	6.46442011032e-10	0.00017537746806039488	MLH1,MSH2,MSH6
152	Anorectal anomaly	C3495676	4	200	6.52525256051e-10	0.0001765389082462253	MLH1,PMS2,MSH2,MSH6
153	Headache	C0018681	4	204	6.84091783221e-10	0.00017770034843205576	MLH1,PMS2,MSH2,MSH6
158	Neurological speech impairment	C0037822	5	553	7.50936091087e-10	0.00018350754936120788	MLH1,PCNA,PMS2,MSH2,MSH6
159	Depression	C0812393	4	212	8.22206525086e-10	0.00018466898954703833	MLH1,PMS2,MSH2,MSH6
160	Abnormality of the pancreas	C4025751	4	212	8.22206525086e-10	0.00018583042973286876	MLH1,PMS2,MSH2,MSH6
161	Medullary carcinoma	C0206693	3	57	8.68990990277e-10	0.00018699186991869918	MLH1,PCNA,MSH2
162	Anxiety	C0003467	4	214	8.74218919478e-10	0.00018815331010452963	MLH1,PMS2,MSH2,MSH6
163	Neoplasm of the liver	C0023903	6	1290	8.7524321124e-10	0.00018931475029036006	MLH1,PCNA,MSH3,PMS2,MSH2,MSH6
164	Neoplasm by anatomical site	C4023185	5	576	8.97728891225e-10	0.00019047619047619048	MLH1,MSH3,PMS2,MSH2,MSH6
165	Abnormal pyramidal signs	C0234132	4	219	1.00402630654e-09	0.0001916376306620209	MLH1,PMS2,MSH2,MSH6
166	Hyperactivity	C0424295	4	219	1.00402630654e-09	0.00019279907084785133	MLH1,PMS2,MSH2,MSH6
167	Mortality/Aging	C4022499	4	223	1.04270880819e-09	0.00019396051103368175	MLH1,PMS2,MSH2,MSH6
168	Age of death	C1546180	4	223	1.04270880819e-09	0.0001951219512195122	MLH1,PMS2,MSH2,MSH6
169	Malabsorption	C0024523	4	224	1.08298348067e-09	0.00019628339140534263	MLH1,PMS2,MSH2,MSH6
170	Ovarian adenocarcinoma	C0948216	3	61	1.09746434163e-09	0.00019744483159117305	MLH1,PCNA,MSH3
171	Colonic Polyps	C0009376	3	61	1.09746434163e-09	0.0001986062717770035	MLH1,PCNA,PMS2
174	Neoplasm of the oral cavity	C0026640	4	226	1.15207388074e-09	0.00020209059233449478	MLH1,PCNA,MSH2,MSH6
175	Constipation	C0009806	4	233	1.27304233821e-09	0.0002032520325203252	MLH1,PMS2,MSH2,MSH6
176	Lymphoma, Large B-Cell, Diffuse	C0024299	6	1362	1.2738616828e-09	0.00020441347270615565	MLH1,PCNA,MSH3,PMS2,MSH2,MSH6
177	Malignant tumor of urinary bladder	C0005684	6	1371	1.2885458256e-09	0.00020557491289198608	MLH1,PCNA,MSH3,PMS2,MSH2,MSH6
178	Hematological neoplasm	C0376545	5	615	1.3628030926e-09	0.0002067363530778165	MLH1,PCNA,PMS2,MSH2,MSH6
179	Renal cell carcinoma, nonpapillary	C0007134	6	1418	1.62828661665e-09	0.00020789779326364693	MLH1,PCNA,MSH3,PMS2,MSH2,MSH6
180	Abnormality of the pituitary gland	C0032002	5	645	1.75768555266e-09	0.00020905923344947735	MLH1,PCNA,PMS2,MSH2,MSH6
181	Neoplasms	C0027651	5	646	1.78952641594e-09	0.00021022067363530778	MLH1,MSH3,PMS2,MSH2,MSH6
182	Abnormality of the hypothalamus-pituitary axis	C4025819	4	252	1.88155757641e-09	0.00021138211382113823	MLH1,PMS2,MSH2,MSH6
183	Malignant Childhood Neoplasm	C0278704	3	76	2.4822174316e-09	0.00021254355400696865	MLH1,MSH3,PMS2
184	Ewing's sarcoma	C0553580	4	268	2.54600462934e-09	0.00021370499419279908	MLH1,PCNA,MSH2,MSH6
185	Gastrointestinal Neoplasms	C0017185	4	268	2.54600462934e-09	0.00021486643437862953	MLH1,PMS2,MSH2,MSH6
186	Salivary gland neoplasm	C0036095	3	78	2.8524742568e-09	0.00021602787456445992	MLH1,MSH2,MSH6
187	Abnormality of joint mobility	C4023216	5	715	3.2605397271e-09	0.00021718931475029035	MLH1,PCNA,PMS2,MSH2,MSH6
188	polyps	C0032584	4	284	3.40047623393e-09	0.0002183507549361208	MLH1,MSH3,MSH2,MSH6
189	Weakness due to upper motor neuron dysfunction	C4021255	4	284	3.40047623393e-09	0.00021951219512195122	MLH1,PMS2,MSH2,MSH6
190	Rectal Carcinoma	C0149978	4	286	3.48742312806e-09	0.00022067363530778165	MLH1,PMS2,MSH2,MSH6
192	Abnormality of vision	C4025846	5	730	3.65398677982e-09	0.00022299651567944252	MLH1,PCNA,PMS2,MSH2,MSH6
193	Neuroblastoma	C0700095	6	1612	3.9741481217e-09	0.00022415795586527292	MLH1,PCNA,MSH3,PMS2,MSH2,MSH6
194	Agenesis of corpus callosum	C0175754	4	301	4.50380588379e-09	0.00022531939605110337	MLH1,PMS2,MSH2,MSH6
195	Glioblastoma	C0017636	6	1645	4.55171900171e-09	0.0002264808362369338	MLH1,PCNA,MSH3,PMS2,MSH2,MSH6
196	Nausea and vomiting	C0027498	4	304	4.76856321097e-09	0.00022764227642276422	MLH1,PMS2,MSH2,MSH6
197	Abnormality of cardiac ventricle	C4025752	4	305	4.86891715834e-09	0.00022880371660859467	MLH1,PMS2,MSH2,MSH6
198	Aplasia/Hypoplasia of the cerebrum	C4024902	5	792	5.94153626299e-09	0.0002299651567944251	MLH1,PCNA,PMS2,MSH2,MSH6
199	Adenocarcinoma, Clear Cell	C0206681	3	94	6.00593086375e-09	0.00023112659698025552	MLH1,PCNA,MSH2
200	Abnormal bleeding	C1458140	4	319	6.07112116136e-09	0.00023228803716608595	MLH1,PMS2,MSH2,MSH6
201	Pancreatic adenocarcinoma	C0281361	4	320	6.14352446693e-09	0.00023344947735191637	MLH1,PMS2,MSH2,MSH6
202	Colon cancer	C0007102	6	1727	6.33654295701e-09	0.0002346109175377468	MLH1,PCNA,MSH3,PMS2,MSH2,MSH6
203	Adenocarcinoma of lung	C0152013	5	815	7.04212632652e-09	0.00023577235772357725	MLH1,PCNA,MSH3,MSH2,MSH6
204	Hyperplastic Polyp	C0333983	3	98	7.05965930159e-09	0.00023693379790940767	MLH1,MSH2,MSH6
205	Neoplasm of the colon	C0009375	5	817	7.10328174058e-09	0.0002380952380952381	MLH1,PCNA,PMS2,MSH2,MSH6
206	Migraine Disorders	C0149931	4	333	7.50311746067e-09	0.00023925667828106855	MLH1,PMS2,MSH2,MSH6
207	Metastatic melanoma	C0278883	4	333	7.50311746067e-09	0.00024041811846689894	MLH1,PCNA,MSH2,MSH6
208	Advanced cancer	C0877373	3	100	7.64327079406e-09	0.0002415795586527294	MLH1,MSH2,MSH6
209	Aplasia/Hypoplasia of the corpus callosum	C1861866	4	342	8.53146242541e-09	0.00024274099883855982	MLH1,PMS2,MSH2,MSH6
211	Alcoholic Liver Diseases	C0023896	3	103	8.64108040677e-09	0.0002450638792102207	MLH1,PMS2,MSH2
212	Abnormality of skin pigmentation	C1260926	4	344	8.7465620302e-09	0.0002462253193960511	MLH1,PMS2,MSH2,MSH6
213	Wilms Tumor	C0027708	4	352	9.89939841212e-09	0.00024738675958188154	MLH1,PCNA,MSH3,PMS2
214	Carcinoma of colon	C0699790	6	1856	1.04728131722e-08	0.000248548199767712	MLH1,PCNA,MSH3,PMS2,MSH2,MSH6
215	Abnormality of the corpus callosum	C1842581	4	358	1.07532446281e-08	0.0002497096399535424	MLH1,PMS2,MSH2,MSH6
216	Abnormality of the gastrointestinal tract	C4023588	5	886	1.15961533709e-08	0.00025087108013937284	MLH1,PCNA,PMS2,MSH2,MSH6
217	Fatigue	C0015672	4	365	1.18079110933e-08	0.00025203252032520324	MLH1,PMS2,MSH2,MSH6
218	Behavioral abnormality	C0233514	5	890	1.18246678005e-08	0.00025319396051103364	MLH1,PCNA,PMS2,MSH2,MSH6
219	Abnormal genital system morphology	C4021096	5	892	1.1996392435e-08	0.00025435540069686414	MLH1,MSH3,PMS2,MSH2,MSH6
223	Leukemia, Lymphocytic, Chronic, B-Cell	C0023418	6	1913	1.29138526539e-08	0.00025900116144018584	MLH1,PCNA,MSH3,PMS2,MSH2,MSH6
224	Thyroid Diseases	C0040128	4	376	1.372456504e-08	0.0002601626016260163	MLH1,PMS2,MSH2,MSH6
225	Abnormal joint morphology	C0240083	5	915	1.39681275435e-08	0.0002613240418118467	MLH1,PCNA,PMS2,MSH2,MSH6
227	Abnormality of higher mental function	C4023352	5	920	1.44358252019e-08	0.00026364692218350754	MLH1,PCNA,PMS2,MSH2,MSH6
228	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 4	C1140680	6	1967	1.56797190787e-08	0.000264808362369338	MLH1,PCNA,MSH3,PMS2,MSH2,MSH6
229	Leukemia, Lymphocytic, Acute, L1	C0023452	4	388	1.60275969163e-08	0.0002659698025551684	MLH1,PCNA,MSH3,MSH6
230	Abnormality of connective tissue	C4025596	5	941	1.65319746781e-08	0.0002671312427409989	MLH1,PCNA,PMS2,MSH2,MSH6
231	Abnormality of muscle morphology	C4023181	5	942	1.66210484265e-08	0.0002682926829268293	MLH1,PCNA,PMS2,MSH2,MSH6
232	Urothelial Carcinoma	C0007138	4	391	1.6627029864e-08	0.0002694541231126597	MLH1,PCNA,MSH2,MSH6
236	Carcinoma, Endometrioid	C0206687	3	123	1.76011193398e-08	0.00027409988385598144	MLH1,MSH2,MSH6
239	Abnormal leukocyte count	C0152009	4	406	2.00792807936e-08	0.0002775842044134727	MLH1,PMS2,MSH2,MSH6
240	Abnormality of cellular immune system	C4023612	4	406	2.00792807936e-08	0.00027874564459930314	MLH1,PMS2,MSH2,MSH6
241	Abnormality of the genital system	C0744356	5	983	2.14391511211e-08	0.00027990708478513353	MLH1,MSH3,PMS2,MSH2,MSH6
242	Abnormality of the cerebral white matter	C0948163	4	412	2.15783125812e-08	0.00028106852497096404	MLH1,PMS2,MSH2,MSH6
245	Abnormality of the larynx	C4021777	3	132	2.33804158256e-08	0.0002845528455284553	MLH1,MSH2,MSH6
247	Abnormal emotion/affect behavior	C1443059	4	430	2.66750784794e-08	0.00028687572590011613	MLH1,PMS2,MSH2,MSH6
248	Abnormality of movement	C0026650	5	1025	2.75176805786e-08	0.0002880371660859466	MLH1,PCNA,PMS2,MSH2,MSH6
249	Lobular carcinoma in situ of breast	C0279563	2	25	2.87911008368e-08	0.00028919860627177704	MLH1,MSH2
250	Ovarian epithelial cancer	C0677886	6	2172	3.13898080861e-08	0.00029036004645760743	MLH1,PCNA,MSH3,PMS2,MSH2,MSH6
251	Abnormality of the cerebral subcortex	C4021207	4	447	3.2397674099e-08	0.0002915214866434379	MLH1,PMS2,MSH2,MSH6
252	Abnormality of the cerebrum	C4021762	5	1054	3.25128740597e-08	0.0002926829268292683	MLH1,PCNA,PMS2,MSH2,MSH6
253	Papillary adenocarcinoma	C0001420	2	26	3.25348537e-08	0.0002938443670150987	MLH1,MSH3
254	Precancerous Conditions	C0032927	4	455	3.54065201602e-08	0.0002950058072009292	MLH1,PCNA,MSH2,MSH6
255	Abnormality of forebrain morphology	C4020967	5	1074	3.63514613966e-08	0.0002961672473867596	MLH1,PCNA,PMS2,MSH2,MSH6
256	Non-Neoplastic Disorder	C1709246	4	461	3.78330019535e-08	0.00029732868757259003	MLH1,PCNA,MSH3,MSH2
257	Bladder carcinoma	C0699885	5	1087	3.90668741801e-08	0.00029849012775842043	MLH1,PCNA,MSH3,MSH2,MSH6
258	Neurofibromatosis, type 1, 162200 (3)	C0027831	3	152	4.12451701681e-08	0.0002996515679442509	MLH1,MSH2,MSH6
259	Abnormality of digestive system physiology	C4293692	5	1132	4.97215448814e-08	0.00030081300813008133	MLH1,PCNA,PMS2,MSH2,MSH6
260	Abnormality of abdomen morphology	C4020869	4	505	5.95378449875e-08	0.00030197444831591173	MLH1,PMS2,MSH2,MSH6
261	Melanoma	C0025202	6	2386	6.05993950575e-08	0.0003031358885017422	MLH1,PCNA,MSH3,PMS2,MSH2,MSH6
266	Visual impairment	C3665347	4	519	6.83090772835e-08	0.00030894308943089433	MLH1,PMS2,MSH2,MSH6
267	Abnormality of central motor function	C4023354	5	1196	6.90731802866e-08	0.00031010452961672473	MLH1,PCNA,PMS2,MSH2,MSH6
268	Attention deficit hyperactivity disorder	C1263846	4	527	7.36671426083e-08	0.0003112659698025552	MLH1,PMS2,MSH2,MSH6
269	Malignant neoplasm of lung	C0242379	6	2460	7.50839106445e-08	0.0003124274099883856	MLH1,PCNA,MSH3,PMS2,MSH2,MSH6
270	Localized skin lesion	C0850826	4	530	7.57860380007e-08	0.00031358885017421603	MLH1,PMS2,MSH2,MSH6
271	Hypertonia	C0026826	4	537	8.08661680951e-08	0.0003147502903600465	MLH1,PMS2,MSH2,MSH6
272	Congenital chromosomal disease	C0008626	4	537	8.08661680951e-08	0.00031591173054587693	MLH1,PCNA,MSH2,MSH6
273	Endometriosis of ovary	C0156344	2	35	8.16795295844e-08	0.00031707317073170733	MLH1,MSH2
274	Medulloblastoma	C0025149	4	543	8.54797725935e-08	0.0003182346109175377	MLH1,PMS2,MSH2,MSH6
275	Abnormality of skin morphology	C4023528	5	1261	9.47058127476e-08	0.0003193960511033682	MLH1,PCNA,PMS2,MSH2,MSH6
276	Colorectal cancer 1	C0009402	6	2543	9.47255290873e-08	0.0003205574912891986	MLH1,PCNA,MSH3,PMS2,MSH2,MSH6
277	Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma	C0079744	4	568	1.06994847426e-07	0.0003217189314750291	MLH1,PCNA,MSH3,MSH2
278	Constitutional symptom	C0009812	4	572	1.10734484804e-07	0.0003228803716608595	MLH1,PMS2,MSH2,MSH6
279	Spots on skin	C0848332	3	198	1.19314831015e-07	0.00032404181184668993	PCNA,PMS2,MSH6
280	Abnormality of the intestine	C0021831	4	584	1.22813149983e-07	0.0003252032520325203	MLH1,PMS2,MSH2,MSH6
281	Intestinal Cancer	C0346627	2	40	1.23098803928e-07	0.0003263646922183507	MLH1,PMS2
282	Esophageal carcinoma	C0152018	4	585	1.2386782422e-07	0.0003275261324041812	MLH1,PCNA,MSH3,MSH2
283	Aplasia involving bones of the extremities	C0000846	5	1321	1.24962217796e-07	0.0003286875725900116	MLH1,PCNA,PMS2,MSH2,MSH6
284	Abnormal peripheral nervous system morphology	C4025831	4	587	1.25977434595e-07	0.0003298490127758421	MLH1,PMS2,MSH2,MSH6
285	Abnormality of facial soft tissue	C4023183	3	203	1.31899644873e-07	0.0003310104529616725	MLH1,MSH2,MSH6
286	Abnormality of blood and blood-forming tissues	C0241657	5	1335	1.33087204257e-07	0.0003321718931475029	MLH1,PCNA,PMS2,MSH2,MSH6
287	Colorectal cancer	C1527249	6	2681	1.37163037262e-07	0.0003333333333333333	MLH1,PCNA,MSH3,PMS2,MSH2,MSH6
288	Prostate carcinoma	C0600139	6	2734	1.57301815462e-07	0.0003344947735191638	MLH1,PCNA,MSH3,PMS2,MSH2,MSH6
289	Abnormality of the skin	C0037268	5	1376	1.59339162864e-07	0.0003356562137049942	MLH1,PCNA,PMS2,MSH2,MSH6
290	Pain	C0030193	4	628	1.76236375382e-07	0.0003368176538908246	MLH1,PMS2,MSH2,MSH6
291	Testicular seminoma	C0036631	3	222	1.88745724161e-07	0.0003379790940766551	MLH1,PCNA,MSH2
300	Breast Neoplasms	C1458155	3	225	1.99147512814e-07	0.000348432055749129	MLH1,MSH2,MSH6
301	Malignant tumor of esophagus	C0546837	4	650	2.09180066379e-07	0.00034959349593495937	MLH1,PCNA,MSH3,MSH2
302	Invasive Ductal Breast Carcinoma	C1134719	3	231	2.21241728382e-07	0.00035075493612078977	MLH1,PCNA,MSH2
303	Abnormality of muscle physiology	C4023182	5	1477	2.43001752054e-07	0.0003519163763066202	MLH1,PCNA,PMS2,MSH2,MSH6
304	Abnormal eye physiology	C4022924	5	1479	2.45002208077e-07	0.0003530778164924506	MLH1,PCNA,PMS2,MSH2,MSH6
305	Abnormal breast morphology	C0742257	3	238	2.49412183351e-07	0.00035423925667828107	MLH1,MSH2,MSH6
306	Hereditary breast and ovarian cancer syndrome	C0677776	2	51	2.59248634671e-07	0.0003554006968641115	MLH1,MSH2
307	Uterine Cancer	C0153567	2	51	2.59248634671e-07	0.00035656213704994197	MLH1,MSH2
308	Bloom syndrome	C0005859	2	51	2.59248634671e-07	0.00035772357723577237	MLH1,MSH2
309	Malignant tumor of prostate	C0376358	6	2940	2.61701497029e-07	0.00035888501742160277	MLH1,PCNA,MSH3,PMS2,MSH2,MSH6
310	Abnormality of digestive system morphology	C4293691	4	682	2.6557149313e-07	0.0003600464576074332	MLH1,PMS2,MSH2,MSH6
311	Morphological abnormality of the gastrointestinal tract	C4021073	4	682	2.6557149313e-07	0.0003612078977932636	MLH1,PMS2,MSH2,MSH6
312	Abnormality of the breast	C4025829	3	242	2.66611568489e-07	0.0003623693379790941	MLH1,MSH2,MSH6
313	Esophageal Neoplasms	C0014859	4	686	2.73433034659e-07	0.0003635307781649245	MLH1,PCNA,MSH3,MSH2
314	Leukoplakia	C0023531	2	52	2.75005141215e-07	0.00036469221835075497	MLH1,MSH2
315	Meningeal Neoplasms	C0025284	2	52	2.75005141215e-07	0.00036585365853658537	PCNA,MSH2
316	Abnormality of cardiovascular system physiology	C4023587	4	700	3.02292840759e-07	0.00036701509872241576	MLH1,PMS2,MSH2,MSH6
317	Seizures, Febrile	C0036572	5	1535	3.05644244469e-07	0.0003681765389082462	MLH1,PCNA,PMS2,MSH2,MSH6
318	Malignant tumor of testis	C0153594	3	251	3.08537045468e-07	0.00036933797909407667	MLH1,PCNA,MSH2
319	Brain Tumor, Primary	C0750974	2	54	3.085784962e-07	0.0003704994192799071	MLH1,PMS2
320	Germ cell neoplasia	C0205851	3	252	3.13437331867e-07	0.0003716608594657375	MLH1,PCNA,MSH6
321	Multiple cafe-au-lait spots	C1861975	2	55	3.26391010552e-07	0.00037282229965156797	MLH1,MSH2
322	Abnormality of the genitourinary system	C0042063	5	1555	3.30153438921e-07	0.00037398373983739836	MLH1,MSH3,PMS2,MSH2,MSH6
323	Adenoma of large intestine	C1302401	3	257	3.39109264114e-07	0.0003751451800232288	MLH1,PCNA,MSH2
324	Abnormality of cardiovascular system electrophysiology	C0243050	5	1568	3.46938713314e-07	0.00037630662020905927	MLH1,PCNA,PMS2,MSH2,MSH6
325	Abnormality of brain morphology	C4021085	5	1573	3.53606364634e-07	0.00037746806039488966	MLH1,PCNA,PMS2,MSH2,MSH6
326	Growth abnormality	C0262361	5	1578	3.60310325243e-07	0.0003786295005807201	MLH1,PCNA,PMS2,MSH2,MSH6
327	Abnormality of the liver	C4021780	4	727	3.64803150132e-07	0.0003797909407665505	MLH1,PMS2,MSH2,MSH6
328	Endometriosis	C0014175	4	727	3.64803150132e-07	0.00038095238095238096	MLH1,PCNA,MSH2,MSH6
329	Abnormality of the stomach	C4025699	3	263	3.71791651799e-07	0.0003821138211382114	MLH1,MSH2,MSH6
330	Cutaneous malignant melanoma 3	C0151779	3	264	3.77482308411e-07	0.0003832752613240418	MLH1,PCNA,MSH2
332	Hepatocellular carcinoma	C2239176	6	3108	3.8623926002e-07	0.00038559814169570266	MLH1,PCNA,MSH3,PMS2,MSH2,MSH6
333	Prostatic Neoplasms	C0033578	5	1606	4.00073812856e-07	0.0003867595818815331	MLH1,PCNA,MSH3,PMS2,MSH2
334	Malignant neoplasm of pancreas	C0346647	5	1625	4.29142433256e-07	0.0003879210220673635	MLH1,PCNA,MSH3,MSH2,MSH6
335	Peripheral neuropathy, myopathy, hoarseness, and hearing loss	C0031117	4	756	4.42989056104e-07	0.000389082462253194	MLH1,PMS2,MSH2,MSH6
336	Neurodevelopmental abnormality	C0679378	5	1639	4.5161083817e-07	0.0003902439024390244	MLH1,PCNA,PMS2,MSH2,MSH6
337	Other specified disorders of breast	C0006145	2	62	4.70101270023e-07	0.0003914053426248548	PCNA,MSH2
338	Cognitive Dysfunction	C0338656	4	769	4.82050245276e-07	0.00039256678281068526	MLH1,PMS2,MSH2,MSH6
339	Abnormality of the integument	C4025761	5	1665	4.95888339613e-07	0.00039372822299651566	MLH1,PCNA,PMS2,MSH2,MSH6
340	Abnormality of the digestive system	C0266015	5	1679	5.21223606498e-07	0.0003948896631823461	MLH1,PCNA,PMS2,MSH2,MSH6
341	Noninfiltrating Intraductal Carcinoma	C0007124	3	291	5.57072509788e-07	0.00039605110336817656	MLH1,PCNA,MSH6
342	 Adenocarcinoma, ovarian, somatic, 167000 (3)	C0001418	5	1700	5.61281031652e-07	0.000397212543554007	MLH1,PCNA,MSH3,MSH2,MSH6
343	Morphological abnormality of the central nervous system	C4021765	5	1722	6.05870039472e-07	0.0003983739837398374	MLH1,PCNA,PMS2,MSH2,MSH6
344	Decreased body weight	C1262477	4	810	6.23698113045e-07	0.0003995354239256678	MLH1,PMS2,MSH2,MSH6
347	Acute lymphoid leukemia	C0023449	4	824	6.79016056604e-07	0.00040301974448315916	MLH1,PCNA,MSH3,MSH2
348	Skin lesion	C0037284	2	70	6.797277885e-07	0.00040418118466898956	MSH2,MSH6
349	Squamous cell carcinoma of the head and neck	C1168401	4	825	6.83083093644e-07	0.00040534262485482	MLH1,PCNA,MSH3,MSH2
350	Abnormality of the musculature	C4021745	5	1765	7.01559901728e-07	0.0004065040650406504	MLH1,PCNA,PMS2,MSH2,MSH6
351	Abnormality of the upper respiratory tract	C4025727	3	309	7.0783561501e-07	0.0004076655052264808	MLH1,MSH2,MSH6
352	Adenomatous Polyps	C0206677	2	72	7.40385351472e-07	0.0004088269454123113	MLH1,MSH6
353	Abnormality of the abdominal organs	C4021764	4	842	7.55759429705e-07	0.0004099883855981417	MLH1,PMS2,MSH2,MSH6
354	Secondary hypertriglyceridemia	C0027627	6	3444	7.9277132381e-07	0.00041114982578397216	MLH1,PCNA,MSH3,PMS2,MSH2,MSH6
355	Upper motor neuron dysfunction	C1839042	4	864	8.58752638999e-07	0.00041231126596980255	MLH1,PMS2,MSH2,MSH6
356	Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse	C0334634	3	327	8.87239208991e-07	0.000413472706155633	MLH1,PCNA,MSH2
357	Abnormality of the endocrine system	C4025823	4	878	9.29913514525e-07	0.0004146341463414634	MLH1,PMS2,MSH2,MSH6
358	Squamous cell carcinoma	C0007137	5	1855	9.42806682391e-07	0.00041579558652729385	MLH1,PCNA,MSH3,MSH2,MSH6
359	Protein Deficiency	C0033626	2	78	9.43762569205e-07	0.0004169570267131243	PMS2,MSH2
360	Williams syndrome	C0175702	2	78	9.43762569205e-07	0.0004181184668989547	PCNA,PMS2
361	Head and Neck Neoplasms	C0018671	3	333	9.5390743482e-07	0.00041927990708478515	MLH1,PCNA,MSH2
366	Abnormality of nervous system morphology	C4022810	5	1875	1.00486367216e-06	0.0004250871080139373	MLH1,PCNA,PMS2,MSH2,MSH6
367	Abnormality of skeletal morphology	C4023165	5	1878	1.01443955647e-06	0.0004262485481997677	MLH1,PCNA,PMS2,MSH2,MSH6
368	Abdominal symptom	C0740651	4	901	1.0569583303e-06	0.00042740998838559815	MLH1,PMS2,MSH2,MSH6
369	Abnormality of the eye	C0015393	5	1900	1.08707817992e-06	0.00042857142857142855	MLH1,PCNA,PMS2,MSH2,MSH6
370	granulosa cell tumor	C0018206	2	83	1.13916468691e-06	0.00042973286875725905	MLH1,PCNA
371	Stomach Neoplasms	C0038356	4	916	1.1470002762e-06	0.00043089430894308945	MLH1,PCNA,MSH2,MSH6
372	Abnormality of the skeletal system	C4021790	5	1961	1.31152769167e-06	0.00043205574912891985	MLH1,PCNA,PMS2,MSH2,MSH6
373	Tumor Progression	C0178874	5	1969	1.34356274673e-06	0.0004332171893147503	MLH1,PCNA,MSH3,MSH2,MSH6
378	Renal neoplasm	C0022665	3	363	1.3450996923e-06	0.00043902439024390245	MLH1,MSH2,MSH6
379	Carcinogenesis	C0596263	6	3723	1.36819015528e-06	0.00044018583042973285	MLH1,PCNA,MSH3,PMS2,MSH2,MSH6
380	Exanthema	C0015230	3	366	1.38994245158e-06	0.0004413472706155633	PCNA,PMS2,MSH6
381	Vestibular Schwannoma	C0027859	2	89	1.40696535644e-06	0.0004425087108013937	PCNA,MSH2
382	Plasmacytoma	C0032131	2	89	1.40696535644e-06	0.0004436701509872242	MLH1,PCNA
383	Clear cell renal cell carcinoma	C0279702	3	368	1.42036855433e-06	0.0004448315911730546	MLH1,PMS2,MSH2
384	Glioma	C0017638	5	1997	1.46107540344e-06	0.00044599303135888505	MLH1,PCNA,PMS2,MSH2,MSH6
385	Autosomal recessive inheritance	C0441748	5	2006	1.50056269033e-06	0.00044715447154471545	MLH1,PCNA,PMS2,MSH2,MSH6
386	Abnormality of body weight	C4025357	4	970	1.52271406317e-06	0.00044831591173054584	MLH1,PMS2,MSH2,MSH6
387	X-linked ichthyosis with steryl-sulfatase deficiency	C0079588	2	92	1.55529076051e-06	0.00044947735191637635	MLH1,MSH2
388	Abnormality of cardiovascular system morphology	C4049796	4	989	1.67596548173e-06	0.00045063879210220675	MLH1,PMS2,MSH2,MSH6
389	Prolactinoma, familial	C0033375	2	95	1.71359665913e-06	0.0004518002322880372	PCNA,MSH6
390	Multiple tumors	C0260037	2	96	1.76863743473e-06	0.0004529616724738676	MLH1,MSH2
391	Lymphoma, Follicular	C0024301	3	389	1.77146050162e-06	0.00045412311265969805	MLH1,PCNA,MSH2
396	Heart Defects, Congenital	C0018798	4	1004	1.8054516252e-06	0.0004599303135888502	MLH1,PMS2,MSH2,MSH6
397	{Gastric cancer risk after H. pylori infection}, 137215 (3)	C0024623	5	2073	1.82356441714e-06	0.0004610917537746806	MLH1,PCNA,MSH3,MSH2,MSH6
398	Biliary Tract Cancer	C0750952	2	97	1.82493489187e-06	0.00046225319396051104	MLH1,MSH2
399	Hypotonia, infantile, with psychomotor retardation	C0026827	4	1017	1.92397526033e-06	0.0004634146341463415	MLH1,PMS2,MSH2,MSH6
400	Stomach cancer	C0699791	5	2109	2.01963577251e-06	0.0004645760743321719	MLH1,PCNA,MSH3,MSH2,MSH6
401	Testicular Germ Cell Tumor	C1336708	2	103	2.18738203361e-06	0.00046573751451800234	MLH1,MSH2
402	Carcinoma of cervix	C0302592	4	1045	2.2002068979e-06	0.00046689895470383274	MLH1,PCNA,PMS2,MSH2
403	Malignant Glioma	C0555198	3	412	2.22612347822e-06	0.0004680603948896632	PCNA,MSH2,MSH6
405	Lip and Oral Cavity Carcinoma	C0220641	3	419	2.380353047e-06	0.0004703832752613241	MLH1,PCNA,MSH2
406	Cancer of mouth	C0153381	3	420	2.40296155007e-06	0.0004715447154471545	MLH1,PCNA,MSH2
407	Intrahepatic Cholangiocarcinoma	C0345905	2	109	2.59469964947e-06	0.0004727061556329849	MLH1,MSH2
408	Cancer of Head and Neck	C0278996	3	430	2.63846869919e-06	0.00047386759581881534	MLH1,MSH2,MSH6
409	Fragile X syndrome	C0016667	2	110	2.66715271979e-06	0.00047502903600464574	MLH1,MSH2
410	Helicobacter Infections	C0079487	2	110	2.66715271979e-06	0.0004761904761904762	MLH1,MSH2
411	Glioblastoma multiforme	C1621958	3	434	2.7374366437e-06	0.00047735191637630664	MSH3,MSH2,MSH6
412	Lung cancer	C0684249	5	2234	2.84136064888e-06	0.0004785133565621371	MLH1,PCNA,MSH3,PMS2,MSH2
417	Chronic atrophic gastritis	C0017154	2	116	3.13007787012e-06	0.00048432055749128924	MLH1,MSH2
418	Mammary Ductal Carcinoma	C0021367	2	117	3.2120646003e-06	0.00048548199767711964	MLH1,PCNA
419	Abnormality of nervous system physiology	C4022811	5	2307	3.437548732e-06	0.0004866434378629501	MLH1,PCNA,PMS2,MSH2,MSH6
420	Triple Negative Breast Neoplasms	C3539878	3	461	3.47873941331e-06	0.0004878048780487805	MSH3,MSH2,MSH6
421	Lung Neoplasms	C0024121	4	1155	3.60546314082e-06	0.0004889663182346109	MLH1,PCNA,MSH2,MSH6
422	Breast carcinoma	C0678222	6	4281	3.63927371838e-06	0.0004901277584204414	MLH1,PCNA,MSH3,PMS2,MSH2,MSH6
423	Liposarcoma	C0023827	2	122	3.64347898829e-06	0.0004912891986062718	MLH1,MSH2
424	Abnormality of the immune system	C4021753	4	1164	3.74612209841e-06	0.0004924506387921022	MLH1,PMS2,MSH2,MSH6
425	Retinoblastoma	C0035335	3	473	3.85219891486e-06	0.0004936120789779326	MLH1,PCNA,MSH2
426	Animal Mammary Neoplasms	C0024667	5	2352	3.85420699611e-06	0.0004947735191637631	MLH1,PCNA,MSH3,MSH2,MSH6
429	Transitional cell carcinoma of the bladder	C0279680	2	132	4.61809512775e-06	0.0004982578397212543	PCNA,MSH3
430	Abnormal muscle tone	C0852413	4	1220	4.72219548497e-06	0.0004994192799070848	MLH1,PMS2,MSH2,MSH6
431	Laryngeal Squamous Cell Carcinoma	C0280324	2	134	4.83174590959e-06	0.0005005807200929152	MLH1,PCNA
432	 {Aerodigestive tract cancer, squamous cell, alcohol-related, protection against} (3)	C0751688	2	134	4.83174590959e-06	0.0005017421602787457	MLH1,MSH2
433	Anaplastic Oligodendroglioma	C0334590	2	135	4.94099351522e-06	0.000502903600464576	MSH2,MSH6
440	Breast-ovarian cancer, familial 1	C0006142	6	4543	5.5172014306e-06	0.0005110336817653891	MLH1,PCNA,MSH3,PMS2,MSH2,MSH6
441	Autosomal dominant non-syndromic sensorineural deafness type DFNA	C0443147	4	1262	5.5785404236e-06	0.0005121951219512195	MLH1,PMS2,MSH2,MSH6
442	Abnormality of the nervous system	C0497552	5	2512	5.68942512236e-06	0.00051335656213705	MLH1,PCNA,PMS2,MSH2,MSH6
445	Acute leukemia	C0085669	3	525	5.82501338264e-06	0.0005168408826945412	PCNA,MSH3,MSH2
446	Hematological Disease	C0018939	2	143	5.87431064847e-06	0.0005180023228803717	PCNA,MSH2
447	Herpes Simplex Infections	C0019348	3	529	6.00285882757e-06	0.000519163763066202	MLH1,PCNA,MSH2
453	Barrett Esophagus	C0004763	2	150	6.7810456249e-06	0.0005261324041811847	MLH1,MSH2
454	Congenital Myotonic Dystrophy	C0410226	2	153	7.19637069391e-06	0.0005272938443670151	MLH1,MSH2
455	Invasive Carcinoma	C1334274	2	154	7.33849370327e-06	0.0005284552845528455	MLH1,PCNA
456	Oligospermia	C0028960	2	155	7.48245081628e-06	0.000529616724738676	MLH1,PMS2
459	Steinert myotonic dystrophy syndrome	C0027126	2	160	8.23037629361e-06	0.0005331010452961672	MLH1,MSH2
463	Squamous cell carcinoma of the skin	C0553723	2	166	9.19122157839e-06	0.000537746806039489	MLH1,MSH2
464	Malignant neoplasm of gallbladder	C0153452	2	168	9.52729316461e-06	0.0005389082462253194	MLH1,MSH2
465	Lymphatic Metastasis	C0024232	2	168	9.52729316461e-06	0.0005400696864111498	MLH1,MSH2
470	Secondary malignant neoplasm of lung	C0153676	3	614	1.08236538633e-05	0.000545876887340302	MLH1,PCNA,MSH2
473	Synovial sarcoma	C0039101	2	178	1.13299735495e-05	0.0005493612078977933	MLH1,MSH3
477	Carcinoid tumor	C0007095	2	183	1.23102892897e-05	0.000554006968641115	MLH1,PCNA
478	Melanocytic nevus	C0027962	2	185	1.27176011924e-05	0.0005551684088269454	PCNA,MSH2
483	B-cell lymphoma	C0079731	3	652	1.37202492004e-05	0.0005609756097560976	MLH1,PCNA,MSH2
484	Well Differentiated Oligodendroglioma	C0751396	2	191	1.39928967114e-05	0.0005621370499419281	PCNA,MSH6
485	Gallbladder Carcinoma	C0235782	2	192	1.42133439698e-05	0.0005632984901277584	MLH1,MSH2
486	Squamous cell carcinoma of lung	C0149782	2	192	1.42133439698e-05	0.0005644599303135889	MLH1,MSH2
487	Leukemogenesis	C0598766	3	660	1.43967128583e-05	0.0005656213704994193	PCNA,PMS2,MSH2
488	Neoplasms, Second Primary	C0085183	2	193	1.44360647736e-05	0.0005667828106852498	MLH1,MSH2
493	Medullary thyroid carcinoma	C0238462	2	201	1.63015026385e-05	0.0005725900116144018	PCNA,MSH2
499	Abnormality of metabolism/homeostasis	C4021768	4	1607	1.82735660886e-05	0.0005795586527293844	MLH1,PMS2,MSH2,MSH6
500	Cervical intraepithelial neoplasia (Cervical dysplasia)	C0206708	2	212	1.91170887671e-05	0.0005807200929152149	MLH1,PCNA
501	Achalasia	C0014848	1	26	2.07592802206e-05	0.0005818815331010453	PCNA
502	Plasmablastic lymphoma	C0079746	1	26	2.07592802206e-05	0.0005830429732868758	MLH1
503	Placental Insufficiency	C0032051	1	26	2.07592802206e-05	0.0005842044134727061	PCNA
504	Pelizaeus-Merzbacher disease	C0205711	1	26	2.07592802206e-05	0.0005853658536585366	MSH3
505	recurrent childhood acute lymphoblastic leukemia	C0278519	1	26	2.07592802206e-05	0.000586527293844367	MSH3
506	Blast Phase	C0005699	2	221	2.16462281101e-05	0.0005876887340301974	PCNA,MSH3
507	Anaplastic thyroid carcinoma	C0238461	2	223	2.22367522628e-05	0.0005888501742160279	PCNA,MSH2
508	Monoclonal Gammapathies	C1136085	1	27	2.24170770464e-05	0.0005900116144018584	MLH1
509	Intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies	C0265294	1	27	2.24170770464e-05	0.0005911730545876888	PCNA
510	Invasive Skin Melanoma	C1708565	1	27	2.24170770464e-05	0.0005923344947735192	PCNA
511	Pancreatic Carcinoma	C0235974	4	1690	2.33795039706e-05	0.0005934959349593496	MLH1,PCNA,MSH3,MSH2
512	Astrocytoma, low grade	C1314694	1	28	2.41383062749e-05	0.0005946573751451801	PCNA
513	Early gastric cancer	C0349530	1	28	2.41383062749e-05	0.0005958188153310104	PCNA
514	Adrenal Gland Hyperfunction	C0001622	1	28	2.41383062749e-05	0.0005969802555168409	PCNA
515	Progressive muscle weakness	C0240421	1	28	2.41383062749e-05	0.0005981416957026713	PCNA
516	Squamous Cell Neoplasms	C0206720	1	29	2.5922970187e-05	0.0005993031358885018	PCNA
517	Pituitary dependent hypercortisolism	C0221406	1	29	2.5922970187e-05	0.0006004645760743321	PCNA
518	Acute myeloid leukemia	C0023467	4	1733	2.6434644982e-05	0.0006016260162601627	MLH1,PCNA,MSH3,MSH2
519	Gastritis	C0017152	2	237	2.66706289952e-05	0.0006027874564459931	MLH1,MSH2
520	Solid tumour	C0280100	3	772	2.66978327502e-05	0.0006039488966318235	MLH1,PCNA,MSH2
521	Abnormal respiratory system morphology	C4022992	3	778	2.75234120817e-05	0.0006051103368176539	MLH1,MSH2,MSH6
522	Verrucae	C0043037	1	30	2.77709284803e-05	0.0006062717770034844	PCNA
523	Lichen Sclerosus et Atrophicus	C0023652	1	31	2.96823279752e-05	0.0006074332171893148	PCNA
524	Early infantile epileptic encephalopathy 8	C3463992	1	31	2.96823279752e-05	0.0006085946573751452	PCNA
525	Arteriovenous hemangioma	C0334533	1	32	3.16570284686e-05	0.0006097560975609756	MSH3
526	 {Porphyria cutanea tarda, susceptibility to}, 176100 (3)	C0162566	1	32	3.16570284686e-05	0.0006109175377468061	PCNA
527	Stenosis	C0678234	1	32	3.16570284686e-05	0.0006120789779326364	MSH2
528	Interstitial lung and liver disease	C0206061	1	32	3.16570284686e-05	0.0006132404181184669	PCNA
529	Abnormality of the face	C4025871	4	1817	3.33084914084e-05	0.0006144018583042973	MLH1,PCNA,MSH2,MSH6
530	Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome	C1332153	1	33	3.36950607795e-05	0.0006155632984901279	MSH2
531	Carney complex	C0406810	1	33	3.36950607795e-05	0.0006167247386759582	MSH2
532	Congenital anomalies of kidney and urinary tract 1, susceptibility to	C0266292	3	820	3.38423631586e-05	0.0006178861788617887	MLH1,MSH2,MSH6
533	Chronic myeloid leukemia	C0023473	3	822	3.41678045168e-05	0.0006190476190476191	MLH1,PCNA,MSH3
534	Abnormality of the upper urinary tract	C4023641	3	827	3.49915022368e-05	0.0006202090592334495	MLH1,MSH2,MSH6
535	Azoospermia	C0004509	2	261	3.55622719006e-05	0.0006213704994192799	MLH1,PMS2
536	Mucosal telangiectasiae	C4022020	1	34	3.57962848377e-05	0.0006225319396051104	PCNA
537	Cervix Diseases	C0007867	1	34	3.57962848377e-05	0.0006236933797909408	PCNA
538	Triploidy syndrome	C0333693	1	34	3.57962848377e-05	0.0006248548199767712	PCNA
539	Primary biliary cirrhosis	C0008312	2	263	3.63806580004e-05	0.0006260162601626016	PCNA,MSH3
540	Experimental Organism Basal Cell Carcinoma	C3811653	2	264	3.67944942228e-05	0.0006271777003484321	MLH1,PMS2
541	Rheumatoid arthritis	C0003873	4	1856	3.69445354648e-05	0.0006283391405342624	PCNA,MSH3,MSH2,MSH6
542	childhood brain tumor	C0220603	1	35	3.79608472181e-05	0.000629500580720093	MSH2
543	Precursor Cell Lymphoblastic Leukemia-Lymphoma	C1961102	3	854	3.96958668225e-05	0.0006306620209059234	PCNA,MSH3,MSH2
544	Benign Ovarian Neoplasm	C0004997	1	36	4.0188578336e-05	0.0006318234610917539	PCNA
545	HTLV-I Infections	C0020097	1	36	4.0188578336e-05	0.0006329849012775842	PCNA
546	Neoplasm Recurrence, Local	C0027643	2	277	4.24597880913e-05	0.0006341463414634147	MLH1,MSH2
547	Odontogenic neoplasm	C0028880	1	37	4.24795398708e-05	0.0006353077816492451	PCNA
548	Condylomata Acuminata	C0009663	1	37	4.24795398708e-05	0.0006364692218350754	PCNA
549	Xeroderma pigmentosum, group A	C0268135	1	38	4.48336755983e-05	0.0006376306620209059	PCNA
550	Esophageal Squamous Cell Carcinoma	C0279626	3	888	4.62660845298e-05	0.0006387921022067364	MLH1,PCNA,MSH2
551	Malignant tumor of cervix	C0007847	3	889	4.64707441558e-05	0.0006399535423925668	MLH1,PCNA,MSH2
552	Gait instability, worse in the dark	C0231686	1	39	4.72509331423e-05	0.0006411149825783971	PCNA
553	Plague	C0032064	1	40	4.97312844393e-05	0.0006422764227642277	PCNA
554	Non-small cell lung carcinoma	C0007131	4	1993	5.22677598184e-05	0.0006434378629500582	MLH1,PCNA,MSH3,MSH2
555	Abnormality of the head	C4021812	4	1995	5.25234957182e-05	0.0006445993031358885	MLH1,PCNA,MSH2,MSH6
556	Abnormality of head or neck	C0854297	4	2021	5.5938916117e-05	0.000645760743321719	MLH1,PCNA,MSH2,MSH6
557	Cholesteatoma	C0008373	1	43	5.75510876419e-05	0.0006469221835075494	PCNA
558	Hyperaldosteronism, familial, type IV	C0020428	1	43	5.75510876419e-05	0.0006480836236933799	PMS2
559	Leukemia, Plasma Cell	C0023484	1	43	5.75510876419e-05	0.0006492450638792102	MLH1
560	Osteoarthritis	C0029408	3	942	5.83077010007e-05	0.0006504065040650406	MSH3,MSH2,MSH6
561	Single tumor	C1298180	1	44	6.02837658724e-05	0.0006515679442508711	MSH2
562	Precursor cell lymphoblastic lymphoma	C0079748	1	44	6.02837658724e-05	0.0006527293844367014	MSH2
563	AIDS Dementia Complex	C0001849	1	44	6.02837658724e-05	0.0006538908246225319	PCNA
564	Primary central nervous system lymphoma	C0280803	1	44	6.02837658724e-05	0.0006550522648083623	MSH2
565	Primary Carcinoma	C1335475	1	44	6.02837658724e-05	0.0006562137049941929	MLH1
566	Pituitary corticotropic cell adenoma	C1306214	1	45	6.30794389931e-05	0.0006573751451800232	PCNA
567	Autosomal recessive polycystic kidney disease	C0085548	1	45	6.30794389931e-05	0.0006585365853658537	PCNA
568	Oropharyngeal disorders	C0553694	1	45	6.30794389931e-05	0.0006596980255516842	PCNA
569	Recurrent tumor	C0521158	2	320	6.52259380918e-05	0.0006608594657375145	MLH1,MSH2
570	Skin Diseases, Genetic	C0037277	1	46	6.59381126105e-05	0.000662020905923345	MLH1
571	CARCINOMA OF VULVA	C0677055	1	46	6.59381126105e-05	0.0006631823461091754	PCNA
572	Crohn Disease	C0010346	3	979	6.77967460885e-05	0.0006643437862950058	MLH1,MSH2,MSH6
573	Li-Fraumeni syndrome	C0085390	1	47	6.88597586102e-05	0.0006655052264808362	PCNA
574	Neck Neoplasms	C0027533	1	48	7.18442084467e-05	0.0006666666666666666	PCNA
575	Prostate cancer, familial	C2931456	1	49	7.48916950546e-05	0.0006678281068524971	MLH1
576	Papillomavirus Infections	C0950124	1	49	7.48916950546e-05	0.0006689895470383275	MLH1
577	Lymphocytic infiltration	C1262091	1	49	7.48916950546e-05	0.000670150987224158	PCNA
578	stage, non-small cell lung cancer	C0280217	1	50	7.80019646236e-05	0.0006713124274099885	PCNA
579	Gastrointestinal stromal tumor	C0238198	2	340	7.8094770425e-05	0.0006724738675958189	MLH1,PCNA
580	Acute respiratory failure	C0264490	1	51	8.11752189211e-05	0.0006736353077816492	PCNA
581	Phyllodes tumor, benign	C0010701	1	51	8.11752189211e-05	0.0006747967479674797	MLH1
582	Chagas Cardiomyopathy	C0007930	1	52	8.44111473142e-05	0.0006759581881533101	PCNA
583	Lehman syndrome	C1851710	1	52	8.44111473142e-05	0.0006771196283391405	PCNA
584	Cervical Adenocarcinoma	C0279672	1	53	8.77099809045e-05	0.0006782810685249709	PCNA
585	Hyperinsulinemia	C0020459	2	355	8.87694000766e-05	0.0006794425087108014	PFKFB1,PCNA
586	Cleft palate with cleft lip	C0158646	1	54	9.10715514633e-05	0.0006806039488966318	PCNA
587	Gorlin syndrome	C0004779	1	54	9.10715514633e-05	0.0006817653890824622	PCNA
588	Low Grade Squamous Intraepithelial Neoplasia	C1302773	1	54	9.10715514633e-05	0.0006829268292682927	PCNA
589	Female Breast Carcinoma	C0007104	1	54	9.10715514633e-05	0.0006840882694541232	MLH1
590	Carcinoma, Neuroendocrine	C0206695	1	55	9.44959490077e-05	0.0006852497096399535	PMS2
591	Autoimmune lymphoproliferative syndrome, type 2	C1328840	1	56	9.79830024678e-05	0.000686411149825784	PCNA
592	Arnold-Chiari malformation	C0003803	1	56	9.79830024678e-05	0.0006875725900116144	PCNA
593	Multiple endocrine neoplasia, type 4	C0027662	1	56	9.79830024678e-05	0.0006887340301974449	PCNA
594	Russell-Silver syndrome	C0175693	1	56	9.79830024678e-05	0.0006898954703832752	PCNA
595	Invasive breast carcinoma	C0853879	2	369	9.95585589187e-05	0.0006910569105691057	MLH1,MSH3
596	T-cell acute lymphoblastic leukemias	C1961099	2	371	0.000101166726602	0.0006922183507549361	PCNA,MSH2
597	Glucocorticoid resistance, generalized	C1841972	1	57	0.000101532832685	0.0006933797909407665	MSH6
598	Biliary tract neoplasm	C0005426	1	57	0.000101532832685	0.0006945412311265969	MSH2
599	Malignant Fibrous Histiocytoma	C0334463	1	57	0.000101532832685	0.0006957026713124274	MSH2
600	Neurologic, endocrine, and pancreatic disease, multisystem, infantile-onset	C0030286	1	57	0.000101532832685	0.000696864111498258	MSH3
601	Neoplasms, Experimental	C0027659	1	58	0.000105145238183	0.0006980255516840883	PCNA
602	Hepatitis	C0019159	2	377	0.000106093333356	0.0006991869918699187	MLH1,PCNA
603	Desmoid tumor	C0079218	1	59	0.000108820426661	0.0007003484320557492	PCNA
604	cancer recurrence	C0920420	1	59	0.000108820426661	0.0007015098722415795	MSH2
605	Adenocarcinoma, Endometrioid	C1569637	1	59	0.000108820426661	0.00070267131242741	MLH1
606	Abnormality of the oral cavity	C4025887	3	1109	0.000110321874138	0.0007038327526132404	MLH1,MSH2,MSH6
607	Abnormality of the respiratory system	C4018871	3	1121	0.000115047845111	0.0007049941927990709	MLH1,MSH2,MSH6
608	Intraosseous mucoepidermoid carcinoma	C0206694	1	62	0.000120221476216	0.0007061556329849012	MSH3
609	Abnormality of the urinary system	C4021821	3	1136	0.000121162750019	0.0007073170731707317	MLH1,MSH2,MSH6
610	Vitreoretinopathy, neovascular inflammatory, 193235 (3)	C0242852	1	63	0.000124146931662	0.0007084785133565621	PCNA
611	Myelodysplastic syndrome	C3463824	2	399	0.000125500185431	0.0007096399535423926	PCNA,MSH2
612	Cholangiocarcinoma	C0206698	2	401	0.000127371518836	0.000710801393728223	PCNA,MSH2
613	Breast Fibrocystic Disease	C0016034	1	64	0.00012813501188	0.0007119628339140535	PCNA
614	Rhabdoid tumors, somatic, 609322 (3)	C0206743	1	64	0.00012813501188	0.0007131242740998839	PCNA
615	Pharyngeal Neoplasms	C0031347	1	64	0.00012813501188	0.0007142857142857143	PCNA
616	Carcinoma, Pancreatic Ductal	C0887833	1	65	0.000132185549357	0.0007154471544715447	PCNA
617	Hodgkin Disease	C0019829	2	409	0.000135039808637	0.0007166085946573752	MLH1,PCNA
618	Chronic Lymphocytic Leukemia	C0023434	3	1176	0.000138637016316	0.0007177700348432055	MLH1,PCNA,MSH2
619	Hepatosplenic schistosomiasis	C0036323	1	68	0.000144711986048	0.000718931475029036	PCNA
620	Neoplasms, Intracranial	C1527390	1	68	0.000144711986048	0.0007200929152148664	MSH3
621	Giant cell tumor of bone	C0206638	1	69	0.000149012379006	0.0007212543554006969	PCNA
622	Malignant neoplasm of colon stage IV	C0278484	1	69	0.000149012379006	0.0007224157955865272	PCNA
623	Benign Prostatic Hyperplasia	C1704272	2	423	0.000149176197575	0.0007235772357723578	MLH1,MSH2
624	Retroviridae Infections	C0035369	1	71	0.000157800127189	0.0007247386759581882	MSH3
625	Well Differentiated Pancreatic Endocrine Tumor	C1337011	1	71	0.000157800127189	0.0007259001161440186	PCNA
626	Cutaneous photosensitivity	C0349506	1	73	0.000166837331521	0.000727061556329849	PCNA
627	Beckwith-Wiedemann syndrome	C0004903	1	73	0.000166837331521	0.0007282229965156795	PCNA
628	Viral hepatitis	C0042721	1	73	0.000166837331521	0.0007293844367015099	MLH1
629	Peutz-Jeghers syndrome	C0031269	1	73	0.000166837331521	0.0007305458768873403	MSH6
630	Multiple Myeloma	C0026764	3	1236	0.000168229301861	0.0007317073170731707	MLH1,PCNA,MSH3
631	Breast Cancer Model	C1511291	1	74	0.000171449372349	0.0007328687572590012	PCNA
632	Papillary thyroid carcinoma	C0238463	2	451	0.000180285273909	0.0007340301974448315	MLH1,PCNA
633	Adenovirus Infections	C0001486	1	76	0.000180860062095	0.000735191637630662	PCNA
634	Meningioma	C0025286	2	452	0.000181468386831	0.0007363530778164924	PCNA,MSH2
635	Epithelial hyperplasia of skin	C0014599	1	78	0.000190519814154	0.000737514518002323	PCNA
636	Sciatic Neuropathy	C0149940	1	78	0.000190519814154	0.0007386759581881533	PCNA
637	Urinary Bladder Neoplasms	C0005695	2	463	0.000194819064959	0.0007398373983739838	PCNA,MSH3
638	Scar conditions and fibrosis of skin	C0241158	1	79	0.00019544289529	0.0007409988385598142	PCNA
639	Benign melanocytic nevus	C1456781	1	80	0.000200428108591	0.0007421602787456446	PCNA
640	Hepatocarcinogenesis	C1512409	2	471	0.000204921510889	0.000743321718931475	PCNA,MSH6
641	Abnormality of the mouth	C0026633	3	1308	0.000209572051411	0.0007444831591173055	MLH1,MSH2,MSH6
642	Chordoma	C0008487	1	83	0.000215756428512	0.0007456445993031359	MSH3
643	Lichen Planus, Oral	C0206139	1	83	0.000215756428512	0.0007468060394889663	PCNA
644	High-Grade Squamous Intraepithelial Lesions	C0333875	1	83	0.000215756428512	0.0007479674796747967	PCNA
645	Carcinoma, Lewis Lung	C0243038	1	83	0.000215756428512	0.0007491289198606272	PCNA
646	Soft Tissue Neoplasms	C0037579	1	86	0.000231642990594	0.0007502903600464576	MSH2
647	Pterygium	C0033999	1	86	0.000231642990594	0.0007514518002322881	PCNA
648	Chronic active hepatitis	C0520463	1	86	0.000231642990594	0.0007526132404181185	PCNA
649	Combined Hepatocellular Carcinoma and Cholangiocarcinoma	C0221287	2	497	0.000240104779713	0.000753774680603949	MLH1,PCNA
650	Thyroid adenoma	C0151468	1	89	0.000248087427528	0.0007549361207897793	PCNA
651	Adult Acute Myeloblastic Leukemia	C0220615	1	90	0.000253692649465	0.0007560975609756098	MSH3
652	DNA Damage	C0012860	1	91	0.000259359778388	0.0007572590011614402	MLH1
653	Actinic keratosis	C0022602	1	91	0.000259359778388	0.0007584204413472706	PCNA
654	Parathyroid adenoma	C0262587	1	93	0.000270879671253	0.000759581881533101	PCNA
655	Chronic ulcerative colitis	C2919828	1	94	0.000276732264568	0.0007607433217189315	MLH1
656	Arteriovenous malformation	C0003857	1	94	0.000276732264568	0.0007619047619047619	MSH3
657	Follicular adenoma	C0205647	1	94	0.000276732264568	0.0007630662020905923	PCNA
658	Skin carcinoma	C0699893	1	95	0.000282646611012	0.0007642276422764228	MSH2
659	Testicular malignant germ cell tumor	C0855197	1	96	0.000288622710683	0.0007653890824622533	PCNA
660	Polyglandular autoimmune syndrome, type 1	C0085409	1	96	0.000288622710683	0.0007665505226480836	MLH1
661	Shy-Drager syndrome	C0037019	1	98	0.000300760132519	0.0007677119628339141	PCNA
662	Leukoencephalopathy, Progressive Multifocal	C0023524	1	101	0.00031942867625	0.0007688734030197445	PCNA
663	Endometrial adenocarcinoma	C1153706	1	103	0.000332182506841	0.000770034843205575	PCNA
664	Non-Hodgkin lymphoma	C0024305	2	556	0.000334037381513	0.0007711962833914053	MSH2,MSH6
665	Adult Acute Lymphocytic Leukemia	C0751606	1	104	0.000338651705407	0.0007723577235772358	MLH1
666	NOONAN-LIKE/MULTIPLE GIANT CELL LESION SYNDROME (disorder)	C0221198	1	105	0.000345182460073	0.0007735191637630662	PCNA
667	Abnormality of the conjunctiva	C4025847	1	105	0.000345182460073	0.0007746806039488966	PCNA
668	precancerous lesions	C0940937	1	106	0.000351774687378	0.000775842044134727	MLH1
669	Thrombocytosis, benign familial microcytic	C0836924	1	106	0.000351774687378	0.0007770034843205575	MSH3
670	Hamartoma	C0018552	1	106	0.000351774687378	0.000778164924506388	MSH3
671	Pancreatic Ductal Adenocarcinoma	C1335302	2	567	0.000353832966436	0.0007793263646922184	MLH1,PCNA
672	Teratoma	C0039538	1	108	0.000365143662496	0.0007804878048780488	PCNA
673	Mixed Salivary Gland Tumor	C0026277	1	109	0.00037192024342	0.0007816492450638793	PCNA
674	Neoplasm of the adrenal gland	C0001624	1	111	0.000385657642892	0.0007828106852497096	MSH2
675	Secondary malignant neoplasm of pancreas	C3266877	3	1540	0.000393949613983	0.0007839721254355401	MLH1,PCNA,MSH2
676	Aortic Aneurysm, Thoracic	C0162872	1	116	0.000421074528033	0.0007851335656213705	MLH1
677	Breast adenocarcinoma	C0858252	1	116	0.000421074528033	0.000786295005807201	PCNA
678	Thromboembolism	C0040038	1	118	0.000435670122547	0.0007874564459930313	PCNA
679	Vascular inflammations	C0947751	1	119	0.000443059661603	0.0007886178861788618	PCNA
680	Hepatic cancer metastatic	C0345904	2	613	0.000444866491886	0.0007897793263646922	MLH1,PCNA
681	Primary Effusion Lymphoma	C1292753	1	121	0.000458022252988	0.0007909407665505227	PCNA
682	Focal segmental glomerulosclerosis	C0017668	1	121	0.000458022252988	0.0007921022067363531	PCNA
683	Tauopathies	C0949664	1	123	0.000473229295287	0.0007932636469221836	PCNA
684	Telangiectases in sun-exposed and nonexposed skin	C0039446	1	123	0.000473229295287	0.000794425087108014	PCNA
685	Skin ulcer	C0037299	1	126	0.000496497811802	0.0007955865272938444	PCNA
686	Small cell lung cancer	C0149925	2	638	0.000500152834929	0.0007967479674796748	PCNA,MSH3
687	Cervical Squamous Cell Carcinoma	C0279671	1	129	0.000520315228028	0.0007979094076655053	PCNA
688	Ischemia	C0022116	2	647	0.000521095065275	0.0007990708478513356	PCNA,MSH2
689	IgA nephropathy, susceptibility to, 3	C0017661	2	650	0.000528200166712	0.0008002322880371661	PCNA,MSH6
690	Ventricular Fibrillation Adverse Event	C0232197	1	131	0.000536498090384	0.0008013937282229965	PCNA
691	Thyroid carcinoma	C0549473	2	659	0.00054989150575	0.000802555168408827	MLH1,PCNA
692	Malignant neoplasm of larynx	C0007107	1	133	0.000552924426848	0.0008037166085946573	MLH1
693	Rett syndrome, congenital variant	C0035372	1	134	0.000561228931187	0.0008048780487804879	PCNA
694	Nasopharyngeal carcinoma, susceptibility to, 3	C2931822	2	671	0.000579700237712	0.0008060394889663183	MLH1,PCNA
695	Colitis, Ulcerative	C0009319	2	679	0.000600142702682	0.0008072009291521487	MLH1,MSH2
696	Adrenoleukodystrophy	C0162309	1	139	0.000603662592238	0.0008083623693379791	PCNA
697	Testicular Neoplasms	C0039590	1	139	0.000603662592238	0.0008095238095238096	PCNA
698	Mammary Tumorigenesis	C1512981	1	141	0.000621060930078	0.00081068524970964	PCNA
699	Mycosis Fungoides	C0026948	1	143	0.000638701799799	0.0008118466898954704	MLH1
700	Monoclonal Gammopathy of Undetermined Significance	C0026470	1	144	0.00064761315188	0.0008130081300813008	MLH1
701	Coinfection	C0275524	1	144	0.00064761315188	0.0008141695702671313	PCNA
702	Neurodegeneration with brain iron accumulation	C0027746	1	144	0.00064761315188	0.0008153310104529616	PCNA
703	Chronic liver disease	C0341439	1	144	0.00064761315188	0.0008164924506387921	PCNA
704	Pes cavus	C0039273	1	155	0.000749628836372	0.0008176538908246226	PCNA
705	androgen independent prostate cancer	C1654637	1	156	0.000759265191869	0.0008188153310104531	PCNA
706	Insulinoma	C0021670	1	157	0.000768961823647	0.0008199767711962834	MLH1
707	Hemangioma	C0018916	1	157	0.000768961823647	0.0008211382113821139	PCNA
708	Polycystic Kidney, Autosomal Dominant	C0085413	1	158	0.00077871874183	0.0008222996515679443	PCNA
709	Monosomy	C0026499	1	158	0.00077871874183	0.0008234610917537747	MSH3
710	Glomerulopathy	C0268731	1	159	0.000788535830614	0.0008246225319396051	PCNA
711	Adenocarcinoma of prostate	C0007112	1	161	0.000808350532783	0.0008257839721254356	PCNA
712	Irritable bowel syndrome with diarrhea	C0022104	1	162	0.000818348182219	0.000826945412311266	MLH1
